Nasdaq to Suspend KaloBios Pharmaceuticals, Inc. on January 13, 2016
2016年1月12日 - 11:45PM
The Nasdaq Stock Market (“Nasdaq”) announced today that, pursuant
to Listing Rule 5815(a)(1)(B), KaloBios Pharmaceuticals, Inc.
(Nasdaq:KBIO) will be suspended from Nasdaq effective January 13,
2016.
Trading in the Company’s securities has been halted since
December 17, 2015. The trading halt will no longer be in effect
upon the suspension of KaloBios from Nasdaq, which would allow the
Company’s securities to be eligible for trading in the
over-the-counter markets under the symbol “KBIOQ.”
A hearing is scheduled for February 25, 2016, to review the
company’s appeal of Nasdaq’s December 18, 2015 delist
determination.
For news and additional information about the Company, including
whether the Company’s securities will trade on another venue,
please review the Company’s public filings or contact the Company
directly.
For more information about Nasdaq trade halts, visit
www.nasdaqtrader.com. For more information about the Nasdaq
delisting process, visit listingcenter.nasdaq.com.
About Nasdaq:
Nasdaq (Nasdaq:NDAQ) is a leading provider of trading, clearing,
exchange technology, listing, information and public company
services across six continents. Through its diverse portfolio of
solutions, Nasdaq enables customers to plan, optimize and execute
their business vision with confidence, using proven technologies
that provide transparency and insight for navigating today's global
capital markets. As the creator of the world's first
electronic stock market, its technology powers more than 70
marketplaces in 50 countries, and 1 in 10 of the world's securities
transactions. Nasdaq is home to more than 3,600 listed companies
with a market value of approximately $8.8 trillion and more than
10,000 corporate clients. To learn more, visit: nasdaq.com/ambition
or business.nasdaq.com.
NDAQO
Nasdaq Media Relations Contact:
Will Briganti
+1.646.441.5012
william.briganti@nasdaq.com
Humanigen (CE) (USOTC:HGEN)
過去 株価チャート
から 7 2024 まで 7 2024
Humanigen (CE) (USOTC:HGEN)
過去 株価チャート
から 7 2023 まで 7 2024
Real-Time news about Humanigen Inc (CE) (その他OTC): 0 recent articles
その他のニュース記事